Marissa Moore
Principal at OMERS Ventures & Creator of The Green Room
San Francisco Bay Area
Invests in
Sectors:
Locations:
Min Investment:
$5.00Max Investment:
$25.00Target Investment:
$10.00
Skills
Education
Lists including Marissa
Work Experience
2022
Principal - Vertical AI
2022
I'm primarily spending time on vertical AI defining resilience in public health and safety (e.g., healthcare, life sciences, law enforcement/public safety, national security, etc.), industrial & supply chain (e.g., manufacturing, freight & logistics, etc.), and critical resources & infrastructure (e.g., energy & power, utilities, telecom, etc.). OMERS Ventures is the direct, early-stage venture arm of the C$138B NAV Canadian pension plan Ontario Municipal Employee Retirement System (OMERS). OMERS manages the pension benefits for 600k+ municipal workers (e.g., firefighters, police officers, etc.) in the province of Ontario. We’re currently investing out of our 4th fund, focusing on B2B software (both infra & app layers) and fintech. We invest in Series A-C rounds with checks ranging in size from $5-25M. Under the OMERS umbrella, we also have Growth Equity, Private Equity Buyouts, Infrastructure, Real Estate (Oxford Properties), and Capital Markets strategies.
2019 - 2021
Managing Analyst - Healthcare & Life Sciences
2019 - 2021
2019 - 2019
Graduate Teaching Assistant - Biopharmaceutical Strategy
2019 - 2019
2017 - 2019
AVP, Equity Research
2017 - 2019
Coverage Areas: Industrial Machinery (e.g., CAT, DE, SWK, etc.)
2017 - 2017
Director of Business Development
2017 - 2017
2013 - 2017
AVP, Institutional Equity Sales
2013 - 2017
Passed levels I, II, and III of the Chartered Financial Analyst Program
2011 - 2013
Molecular Biology Undergraduate Thesis Researcher, Gavis Lab
2011 - 2013
Focus areas: NEUROSCIENCE, GENETICS, CELLULAR DEVELOPMENT ◻ Independently researched & developed methods for screening mRNA asymmetrically localized in D. melanogaster neuromuscular junctions. ◻ Utilized the EP-MS2 method (combining EP transposon insertion with MS2/MCP in vivo fluorescent labeling) to screen for novel localized mRNA transcripts. The goal was to identify which transcripts were asymmetrically localized and then to determine their possible roles in cellular development. ◻ Research was presented as a senior thesis in May of 2013 and was partially included in a scientific publication in G3 Journal in August of 2016 (see publications below).
2012 - 2012
Global Markets Summer Analyst
2012 - 2012